Abstract
Phototherapy holds great promise for disease treatment; however, traditional “always-on” photoagents have been restricted to clinical translation due to their nonspecific response and side effects on normal tissues. Here, we show a tumor microenvironment activated photothermal and photoacoustic agent as an activatable prodrug and probe that allows precise cancer diagnosis and treatment. Such anin siturevitalized therapeutic and contrast agent is achievedviacontrollable plasmonic heating for thermoplasmonic activation. This enables monitoring of signal molecule dynamics, real-time photothermal and photoacoustic imaging of tumors and lymph node metastasis, and targeted photothermal therapy without unwanted phototoxicity to normal tissues. Our study provides a practical solution to the non-specificity problem in phototherapy and offers precision cancer therapeutic and theranostic strategies. This work may advance the development of ultrasensitive disease diagnosis and precision medicine.
Cite
CITATION STYLE
Liu, Y., Mo, F., Hu, J., Jiang, Q., Wang, X., Zou, Z., … Liu, X. (2021). Precision photothermal therapy and photoacoustic imaging byin situactivatable thermoplasmonics. Chemical Science, 12(29), 10097–10105. https://doi.org/10.1039/d1sc02203b
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.